HROW - HARROW, INC.
24.59
0.470 1.911%
Share volume: 317,824
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$24.12
0.47
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-13-2024 | 08-07-2024 | 11-14-2024 | 03-27-2025 | |
| Total revenue | 34.587 M | 48.939 M | 49.257 M | 66.831 M | |
| Cost of revenue | 10.553 M | 12.539 M | 12.018 M | 14.135 M | |
| Gross profit | 24.034 M | 36.400 M | 37.239 M | 52.696 M | |
| 51.45% | 2.30% | 41.51% | |||
| Operating expenses | 30.962 M | 34.870 M | 35.918 M | 39.544 M | |
| Selling general and admin | 28.813 M | 31.817 M | 33.645 M | 34.789 M | |
| Research and development | 2.149 M | 3.053 M | 2.273 M | 4.755 M | |
| Total expenses | 30.962 M | 34.870 M | 35.918 M | 39.797 M | |
| 12.62% | 3.01% | 10.80% | |||
| Operating income | -6.928 M | 1.530 M | 1.321 M | 12.899 M | |
| Ebit | -6.902 M | 1.576 M | 1.325 M | 12.638 M | |
| Pretax income | -13.565 M | -5.818 M | -4.200 M | 6.263 M | |
| -57.11% | -27.81% | -249.12% | |||
| Income tax | 0.000 | 655.000 K | 20.000 K | -514.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -13.565 M | -6.473 M | -4.220 M | 6.777 M | |
| 52.28% | 34.81% | 260.59% |
